Plunkett Research Online: Brickell Biotech Inc

BRICKELL BIOTECH INC (BBI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on developing innovative prescription therapeutics for the treatment of debilitating skin diseases. The firm’s pipeline consists of potential novel therapeutics for hyperhidrosis and other prevalent dermatological conditions......



Brickell Biotech Inc
Ticker: BBI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 720-505-4755
Fax:
Address: 5777 Central Avenue
Suite 102
Boulder, CO 80301 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Delivery Systems
Skin Disease Treatments
Clinical-State Pharmaceuticals
Pharmaceutical Development
Contacts Description

Vijay Samant CEO/Director/President
Anthony Ramos CFO/Chief Accounting Officer/Vice President
See More
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on developing innovative prescription therapeutics for the treatment of debilitating skin diseases. The firm’s pipeline consists of potential novel therapeutics for hyperhidrosis and other prevalent dermatological conditions......See More See More

Auditor: EY
Legal Advisor: Cooley LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Sofpironium Bromide
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: